A new study led by a researcher at New York Institute of Technology provides insight that could change how scientists and clinicians understand genetic predisposition to breast cancer, a condition that affects one in eight U.S. women in her lifetime.
Tag: Genetic Predisposition to Disease
SHE Center at Dana-Farber and Silverberry Genomix form SHE Biobank, a Population Health Initiative for Research and Education
Dana-Farber and Silverberry Genomix launch the SHE Biobank initiative — a long-term study to investigate the impact of genetic predisposition and environmental exposure to development of disease.